Chemoinformaics analysis of 3-METHYLBUTANENITRILE
| Molecular Weight | 83.134 | nRot | 1 |
| Heavy Atom Molecular Weight | 74.062 | nRig | 30 |
| Exact Molecular Weight | 83.0735 | nRing | 0 |
| Solubility: LogS | -4.376 | nHRing | 0 |
| Solubility: LogP | 2.922 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 15.4511 |
| nHD | 0 | BPOL | 9.59886 |
| QED | 0.45 |
| Synth | 4.7 |
| Natural Product Likeliness | 2.096 |
| NR-PPAR-gamma | 0.53 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.936 |
| Pgp-sub | 0.002 |
| HIA | 0.12 |
| CACO-2 | -4.869 |
| MDCK | 0.0000159 |
| BBB | 0.83 |
| PPB | 0.684488 |
| VDSS | 0.645 |
| FU | 0.265846 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.21 |
| CYP2c19-inh | 0.208 |
| CYP2c19-sub | 0.163 |
| CYP2c9-inh | 0.576 |
| CYP2c9-sub | 0.282 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.242 |
| CYP3a4-inh | 0.877 |
| CYP3a4-sub | 0.382 |
| CL | 15.376 |
| T12 | 0.615 |
| hERG | 0.044 |
| Ames | 0.007 |
| ROA | 0.75 |
| SkinSen | 0.038 |
| Carcinogencity | 0.059 |
| EI | 0.009 |
| Respiratory | 0.903 |
| NR-Aromatase | 0.179 |
| Antiviral | No |
| Prediction | 0.944861 |